REP. BLILEY REITERATES INTEREST IN "FUNDAMENTAL" REFORM FOR FDA; COMMERCE COMMITTEE CHAIRMAN VOWS TO HOLD HEARINGS, MOVE BILL IN EARLY 1996
This article was originally published in The Gray Sheet
Executive Summary
FDA cannot be left to its own devices when it comes to reform efforts, House Commerce Committee Chairman Thomas Bliley (R-Va.) asserted in calling for "fundamental" FDA reform legislation at the 39th annual Food and Drug Law Institute Educational Conference Dec. 12 in Washington, D.C.